Covered recipient · General Payments record
AMANDA TURNER
General Payments · PY2025
$167.14
- Reported across 9 records
- CMS publication 2026-06-30
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- This total is the sum of the individual General Payments record amounts CMS published for the labeled program year(s); each record amount is used unmodified. The total itself is computed by this site. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2025 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $167.14 | 9 |
By paying entity
PY2025 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Novo Nordisk AS | $89.41 | 5 |
| Esperion Therapeutics, Inc. | $23.69 | 1 |
| Seqirus USA Inc | $20.60 | 1 |
| AQUESTIVE THERAPEUTICS, INC. | $18.02 | 1 |
| Exact Sciences Corporation | $15.42 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2025 | $167.14 | 9 |
Payment records · PY2025 (9)
Ordering applied by this site (paying entity, then date) · record values are shown as CMS published them
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Aquestive Therapeutics, Inc. | $18.02 | 02/06/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1241180258 | CMS |
| Esperion Therapeutics, Inc. | $23.69 | 08/08/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1243978257 | CMS |
| Exact Sciences Corporation | $15.42 | 10/24/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1235221515 | CMS |
| Novo Nordisk Inc | $19.54 | 04/16/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1195105806 | CMS |
| Novo Nordisk Inc | $23.05 | 05/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1195105078 | CMS |
| Novo Nordisk Inc | $18.05 | 06/11/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1195105326 | CMS |
| Novo Nordisk Inc | $14.57 | 09/17/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1195105728 | CMS |
| Novo Nordisk Inc | $14.20 | 11/12/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1195104974 | CMS |
| Seqirus USA Inc | $20.60 | 09/23/2025 | Food and Beverage | Undisputed | 06/30/2026 | 1201096980 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-06-30
- Program years on this page
- 2025
- Source files
- Dataset page · Bulk file · PY2025
- Generated from
- OP_DTL_GNRL_PGYR2025_P06302026_06032026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.